Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination

Class switch towards spike protein-specific IgG4 antibodies after SARS-CoV-2 mRNA vaccination depends on prior infection history

SARS-CoV-2 vaccination diversifies the CD4+ spike-reactive T cell repertoire in patients with prior SARS-CoV-2 infection - eBioMedicine

Antibody Fc-binding profiles and ACE2 affinity to SARS-CoV-2 RBD variants

Frontiers mRNA vaccines against SARS-CoV-2 induce comparably low long-term IgG Fc galactosylation and sialylation levels but increasing long-term IgG4 responses compared to an adenovirus-based vaccine

The BNT162b2 mRNA SARS-CoV-2 vaccine induces transient afucosylated IgG1 in naive but not in antigen-experienced vaccinees - eBioMedicine

Class switch towards spike protein-specific IgG4 antibodies after SARS-CoV-2 mRNA vaccination depends on prior infection history

Non-neutralizing functions in anti-SARS-CoV-2 IgG antibodies - ScienceDirect

Class switch towards non-inflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination – ScienceOpen

Repeat SARS-CoV-2 mRNA Vaccination Tied to Rise in Unexpected Antibody Subset

Class switch towards non-inflammatory IgG isotypes after repeated SARS-CoV-2 mRNA vaccination

Efficacy of mRNA-1273 and Novavax ancestral or BA.1 spike booster vaccines against SARS-CoV-2 BA.5 infection in nonhuman primates

Both COVID-19 infection and vaccination induce high-affinity cross-clade responses to SARS-CoV-2 variants - ScienceDirect